Amendment of regulation 31 of the principal Regulations
This section has no associated Explanatory Memorandum
17. In regulation 31 of the principal Regulations (suspension or termination of clinical trial), in paragraph (1), in paragraph (a), in head (ii), for “24(4)” substitute “24(5)”.